Measuring adherence to antiretroviral treatment in resource-poor settings: The clinical validity of key indicators

BMC Health Services Research

Volumn 10, Issue , 2010, Pages

  Ross Degnan, Dennis ^a   Pierre Jacques, Marsha ^a   Zhang, Fang ^a   Tadeg, Hailu ^b   Gitau, Lillian ^c   Ntaganira, Joseph ^d   Balikuddembe, Robert ^e   Chalker, John ^f   Wagner, Anita K ^a   Inrud, I A A ^g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Management Sciences for Health   (Ethiopia)

^c ACK Garden House   (Kenya)

^d UNIVERSITY OF RWANDA   (Rwanda)

^e MAKERERE UNIVERSITY   (Uganda)

^f Center for Pharmaceutical Management   (United States)

^g Initiative on Adherence to Antiretrovirals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; HEALTH CARE FACILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COMPLIANCE; PILOT STUDY; RETROSPECTIVE STUDY; STATISTICS; VALIDATION STUDY; WEIGHT GAIN;

ADULT; AFRICA, EASTERN; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HEALTH FACILITIES; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; PILOT PROJECTS; RETROSPECTIVE STUDIES; WEIGHT GAIN;

EID: 77649288522     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-42     Document Type: Article

References (15)

1. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. CJ Gill DH Hamer JL Simon DM Thea LL Sabin, AIDS 2005 19 1243 1249 10.1097/01.aids.0000180094.04652.3b 16052078
2. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. L Ferradini A Jeannin L Pinoges P Izopet D Odhiambo L Mankhambo G Karungi E Szumilin S Balandine G Fedida MP Carrieri B Spire N Ford J Tassie PJ Guerin C Brasher, Lancet 2006 367 1335 1342 10.1016/S0140-6736(06)68580-2 16631912
3. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. K Wools-Kaloustian S Kimaiyo L Diero A Siika J Sidle CT Yiannoutsos B Musick R Einterz KH Fife WM Tierney, AIDS 2006 20 41 48 10.1097/01.aids.0000196177.65551.ea 16327318
4. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. JJ van Oosterhout N Bodasing JJ Kumwenda C Nyirenda J Mallewa PR Cleary MP de Baar R Schuurman DM Burger EE Zijlstra, Trop Med Int Health 2005 10 464 470 10.1111/j.1365-3156.2005.01409.x 15860093
5. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. A Ammassari MP Trotta R Murri F Castelli P Narciso P Noto J Vecchiet AD Monforte AW Wu A Antinori, JAIDS 2002 31 123 S127 12562034
6. A comparison study of multiple measures of adherence to HIV protease inhibitors. H Liu CE Golin LG Miller RD Hays CK Beck S Sanandaji J Christian T Maldonado D Duran AH Kaplan NS Wenger, Ann Intern Med 2001 134 968 977 11352698
7. Antiretroviral adherence interventions: A review of current literature and ongoing studies. JM Simoni PA Frick DW Pantalone BJ Turner, Intl AIDS Society-USA 2003 11 185 98
8. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. PT Nieuwkerk FJ Oort, J Acquir Immune Defic Syndr 2005 38 445 448 10.1097/01.qai.0000147522.34369.12 15764962
9. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. JH Oyugi J Byakika-Tusiime ED Charlebois C Kityo R Mugerwa P Mugyenyi DR Bangsberg, J Acquir Immune Defic Syndr 2004 36 5 1100 02 10.1097/00126334- 200408150-00014 15247564
10. Adherence to medication. L Osterberg T Blaschke, New Engl J Med 2005 353 487 497 10.1056/NEJMra050100 16079372
11. The assessment of refill compliance using pharmacy records: methods, validity, and applications. JF Steiner AV Prochazka, J Clin Epidemiol 1997 50 105 116 10.1016/S0895-4356(96)00268-5 9048695
12. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting. CK Fairley A Permana TRH Read, HIV Medicine 2005 6 366 369 10.1111/j.1468-1293.2005.00322.x 16156886
13. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Farley S Hines A Musk S Ferrus V Tepper, J Acquir Immune Defic Syndr 2003 33 211 218 10.1097/00126334-200306010-00016 12794557
14. Monitoring adherence and defaulting for antiretroviral therapy in five East African countries: An urgent need for standards. J Chalker T Andualem O Minzi J Ntaganira A Ojoo P Waako D Ross-Degnan for the International Network for the Rational Use of Drugs Initiative on Adherence to Antiretroviral Therapy (INRUD-IAA), J Int Assoc Physicians AIDS Care 2008 7 4 193 199 10.1177/1545109708320687
15. Measuring adherence to antiretroviral treatment in resource-poor settings: A health system approach. J Chalker T Andualem L Gitau J Ntaganira P Waako C Obua D Ross-Degnan INRUD IAA, BMC Health Services Research 2010 10 43 10.1186/1472-6963-10-43 20170479